laparoscopic urology. Urological procedure associated with injury or harm in therapeutic use
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group will receive a number 300 mg capsule of gabapentin 2 hours before surgery and a number 300 mg capsule daily until 48 hours after
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients candidate for laparoscopic urology Age between 18 and 65 years Patients with physical status one and two according to the criteria of the American Anesthesia Association (ASA I, II)
Exclusion criteria
Exclusion criteria: Having any coagulopathy Opium addiction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 6, 24, 12 and 48 hours after surgery. Method of measurement: Visual analogue scale (VAS).;Nausea and vomiting. Timepoint: 6, 24, 12 and 48 hours after surgery. Method of measurement: Post operative nausea and vomiting scale (PONV scale). | — |
Secondary
| Measure | Time frame |
|---|---|
| Dosage of analgesic. Timepoint: Up to 48 hours after surgery. Method of measurement: milligram.;Receiving anti-nausea and vomiting medicine. Timepoint: Up to 48 hours after surgery. Method of measurement: yes/ no. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Saman Farshid
Oroumia University of Medical Sciences
Outcome results
None listed